المؤلفون: Price MO; Cornea Research Foundation of America, Indianapolis, IN; and., Feng MT; Price Vision Group, Indianapolis, IN., Gang A; Price Vision Group, Indianapolis, IN., Price FW Jr; Price Vision Group, Indianapolis, IN.

المصدر: Cornea [Cornea] 2024 Aug 01; Vol. 43 (8), pp. 1028-1030. Date of Electronic Publication: 2023 Sep 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8216186 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1536-4798 (Electronic) Linking ISSN: 02773740 NLM ISO Abbreviation: Cornea Subsets: MEDLINE

مواضيع طبية MeSH: Fuchs' Endothelial Dystrophy*/surgery , Descemet Stripping Endothelial Keratoplasty* , Graft Rejection*/prevention & control , Loteprednol Etabonate*/therapeutic use , Intraocular Pressure*/physiology, Humans ; Female ; Prospective Studies ; Male ; Aged ; Middle Aged ; Ophthalmic Solutions ; Aged, 80 and over ; Visual Acuity/physiology

المؤلفون: Ozdemir S; Department of Pharmaceutical Technology, Faculty of Pharmacy, Istanbul Health and Technology University, Istanbul, Turkey., Uner B; Department of Pharmaceutical and Administrative Sciences, University of Health Science and Pharmacy in St. Louis, St. Louis, Missouri, USA. Burcu.uner@uhsp.edu.; Department of Pharmaceutical Technology, Faculty of Pharmacy, Istanbul Kent University, Istanbul, Turkey. Burcu.uner@uhsp.edu.; Department of Anesthesiology, Center for Clinical Pharmacology, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA. Burcu.uner@uhsp.edu.

المصدر: AAPS PharmSciTech [AAPS PharmSciTech] 2024 May 30; Vol. 25 (5), pp. 119. Date of Electronic Publication: 2024 May 30.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 100960111 Publication Model: Electronic Cited Medium: Internet ISSN: 1530-9932 (Electronic) Linking ISSN: 15309932 NLM ISO Abbreviation: AAPS PharmSciTech Subsets: MEDLINE

مواضيع طبية MeSH: Liposomes* , Delayed-Action Preparations*/administration & dosage , Delayed-Action Preparations*/pharmacokinetics , Loteprednol Etabonate*/administration & dosage , Loteprednol Etabonate*/pharmacokinetics , Dry Eye Syndromes*/drug therapy, Animals ; Rabbits ; Cattle ; Drug Liberation ; Particle Size ; Disease Models, Animal ; Administration, Ophthalmic ; Biological Availability ; Drug Delivery Systems/methods ; Eye/metabolism ; Eye/drug effects ; Aqueous Humor/metabolism ; Chemistry, Pharmaceutical/methods ; Ophthalmic Solutions/administration & dosage ; Ophthalmic Solutions/pharmacokinetics

المؤلفون: Chen J; Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Cambridge, MA, USA., Tang LWT; Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Groton, CT, USA., Jordan S; Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Groton, CT, USA., Harrison M; Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Groton, CT, USA., Gualtieri GM; Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Groton, CT, USA., DaSilva E; Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Groton, CT, USA., Morris D; Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Groton, CT, USA., Bora G; Discovery Sciences, Pfizer Worldwide Research and Development, Groton, CT, USA., Che Y; Discovery Sciences, Pfizer Worldwide Research and Development, Groton, CT, USA., Di L; Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Groton, CT, USA. lidicanton@gmail.com.

المصدر: The AAPS journal [AAPS J] 2024 Feb 16; Vol. 26 (2), pp. 26. Date of Electronic Publication: 2024 Feb 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association of Pharmaceutical Scientists Country of Publication: United States NLM ID: 101223209 Publication Model: Electronic Cited Medium: Internet ISSN: 1550-7416 (Electronic) Linking ISSN: 15507416 NLM ISO Abbreviation: AAPS J Subsets: MEDLINE

مواضيع طبية MeSH: Cytochrome P-450 CYP3A Inhibitors*/pharmacology , Cytochrome P-450 CYP3A*/metabolism, Humans ; Loteprednol Etabonate ; Cytochrome P-450 Enzyme System/metabolism ; Microsomes, Liver/metabolism

المؤلفون: Barabino S; Ocular Surface and Dry Eye Center, ASST Fatebenefratelli-Sacco, L. Sacco Hospital, University of Milan, Milan, Italy., Montaldo E; Ospedale San Raffaele, Milan, Italy., Mingari MC; Department of Experimental Medicine, University of Genoa, Genova, Italy., Mazzotta C; Ophthalmology Unit SL Toscana Sud-Est, Siena-Arezzo, Italy., Giuffrida S; Former Bausch+Lomb, Milan, Italy., Rolando M; IS.PRE Oftalmica, Genova, Italy.

المصدر: European journal of ophthalmology [Eur J Ophthalmol] 2022 Jul; Vol. 32 (4), pp. 2452-2458. Date of Electronic Publication: 2021 Sep 29.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: SAGE Publishing Country of Publication: United States NLM ID: 9110772 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1724-6016 (Electronic) Linking ISSN: 11206721 NLM ISO Abbreviation: Eur J Ophthalmol Subsets: MEDLINE

مواضيع طبية MeSH: Dry Eye Syndromes*/diagnosis , Dry Eye Syndromes*/drug therapy , Loteprednol Etabonate*/therapeutic use, HLA-DR Antigens/genetics ; Humans ; Inflammation ; Ophthalmic Solutions/therapeutic use ; Pilot Projects

المؤلفون: Paton DM; Professor Emeritus of Pharmacology, University of Auckland, Auckland, New Zealand.; Professor Emeritus of Oral Biology, University of Alberta, Edmonton, Alberta, Canada. dmpaton62@gmail.com.

المصدر: Drugs of today (Barcelona, Spain : 1998) [Drugs Today (Barc)] 2022 Feb; Vol. 58 (2), pp. 77-84.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Clarivate Analytics Country of Publication: Spain NLM ID: 101160518 Publication Model: Print Cited Medium: Print ISSN: 1699-3993 (Print) Linking ISSN: 16993993 NLM ISO Abbreviation: Drugs Today (Barc) Subsets: MEDLINE

مواضيع طبية MeSH: Dry Eye Syndromes*/drug therapy , Loteprednol Etabonate*/therapeutic use, Clinical Trials, Phase II as Topic ; Clinical Trials, Phase III as Topic ; Humans ; Ophthalmic Solutions/therapeutic use ; United States ; United States Food and Drug Administration

المؤلفون: Zhang X; Department of Pharmacy, Eye & ENT Hospital, Fudan University, No. 83 Fenyang Road, Shanghai, 200031, China., Shen Z; Department of Pharmacy, Eye & ENT Hospital, Fudan University, No. 83 Fenyang Road, Shanghai, 200031, China., Sun H; Department of Pharmacy, Eye & ENT Hospital, Fudan University, No. 83 Fenyang Road, Shanghai, 200031, China., Bu F; Department of Pharmacy, Eye & ENT Hospital, Fudan University, No. 83 Fenyang Road, Shanghai, 200031, China., Huang T; Department of Pharmacy, Eye & ENT Hospital, Fudan University, No. 83 Fenyang Road, Shanghai, 200031, China. taominhuang@139.com.

المصدر: International ophthalmology [Int Ophthalmol] 2023 Jul; Vol. 43 (7), pp. 2477-2486. Date of Electronic Publication: 2023 Mar 04.

نوع المنشور: Meta-Analysis; Journal Article

بيانات الدورية: Publisher: Kluwer Country of Publication: Netherlands NLM ID: 7904294 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2630 (Electronic) Linking ISSN: 01655701 NLM ISO Abbreviation: Int Ophthalmol Subsets: MEDLINE

مواضيع طبية MeSH: Refractive Surgical Procedures*/adverse effects , Corneal Opacity* , Ocular Hypertension*, Humans ; Loteprednol Etabonate/adverse effects ; Fluorometholone/therapeutic use ; Cornea/surgery

المصدر: The Medical letter on drugs and therapeutics [Med Lett Drugs Ther] 2021 May 17; Vol. 63 (1624), pp. 75-77.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: The Medical Letter Country of Publication: United States NLM ID: 2985240R Publication Model: Print Cited Medium: Internet ISSN: 1523-2859 (Electronic) Linking ISSN: 0025732X NLM ISO Abbreviation: Med Lett Drugs Ther Subsets: MEDLINE

مواضيع طبية MeSH: Anti-Allergic Agents/*therapeutic use , Dry Eye Syndromes/*drug therapy , Loteprednol Etabonate/*therapeutic use, Anti-Allergic Agents/administration & dosage ; Anti-Allergic Agents/adverse effects ; Drug Approval ; Humans ; Loteprednol Etabonate/administration & dosage ; Loteprednol Etabonate/adverse effects ; Ophthalmic Solutions ; Randomized Controlled Trials as Topic ; United States ; United States Food and Drug Administration

المؤلفون: Korenfeld M; Comprehensive Eye Care, Ltd, Washington, MO., Nichols KK; School of Optometry, University of Alabama, Birmingham, AL., Goldberg D; Wolstan and Goldberg Eye Associates, Torrance, CA., Evans D; Total Eye Care, PA, Memphis, TN., Sall K; Sall Research Medical Center, Artesia, CA., Foulks G; Department of Ophthalmology, University of Louisville, Louisville, KY; and., Coultas S; Kala Pharmaceuticals, Inc, Watertown, MA., Brazzell K; Kala Pharmaceuticals, Inc, Watertown, MA.

المصدر: Cornea [Cornea] 2021 May 01; Vol. 40 (5), pp. 564-570.

نوع المنشور: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8216186 Publication Model: Print Cited Medium: Internet ISSN: 1536-4798 (Electronic) Linking ISSN: 02773740 NLM ISO Abbreviation: Cornea Subsets: MEDLINE

مواضيع طبية MeSH: Anti-Allergic Agents/*administration & dosage , Dry Eye Syndromes/*drug therapy , Loteprednol Etabonate/*administration & dosage, Administration, Ophthalmic ; Adolescent ; Adult ; Aged ; Aged, 80 and over ; Anti-Allergic Agents/adverse effects ; Double-Blind Method ; Drug-Related Side Effects and Adverse Reactions/diagnosis ; Drug-Related Side Effects and Adverse Reactions/etiology ; Eye Pain/chemically induced ; Female ; Humans ; Intraocular Pressure/drug effects ; Loteprednol Etabonate/adverse effects ; Male ; Middle Aged ; Nanoparticles ; Ophthalmic Solutions ; Suspensions ; Tonometry, Ocular ; Visual Acuity/drug effects ; Young Adult

المؤلفون: Uner B; Institute of Graduate Studies in Health Sciences, Istanbul University, Istanbul, Turkey. burcu.uner@uhsp.edu.; Faculty of Pharmacy, Yeditepe University, Atasehir, 34755, Istanbul, Turkey. burcu.uner@uhsp.edu.; University of Health Science and Pharmacy in St. Louis, 1 Pharmacy Place, St. Louis, Missouri, 63110-1088, USA. burcu.uner@uhsp.edu., Ozdemir S; Faculty of Pharmacy, Istanbul Health and Technology University, Zeytinburnu, 34010, Istanbul, Turkey., Tas C; Faculty of Pharmacy, Yeditepe University, Atasehir, 34755, Istanbul, Turkey., Uner M; Faculty of Pharmacy, Istanbul University, Beyazıt, 34116, Istanbul, Turkey., Ozsoy Y; Faculty of Pharmacy, Istanbul University, Beyazıt, 34116, Istanbul, Turkey.

المصدر: AAPS PharmSciTech [AAPS PharmSciTech] 2023 Mar 28; Vol. 24 (4), pp. 92. Date of Electronic Publication: 2023 Mar 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 100960111 Publication Model: Electronic Cited Medium: Internet ISSN: 1530-9932 (Electronic) Linking ISSN: 15309932 NLM ISO Abbreviation: AAPS PharmSciTech Subsets: MEDLINE

مواضيع طبية MeSH: Drug Carriers*/chemistry , Nanoparticles*/chemistry, Humans ; Loteprednol Etabonate ; Lipids/chemistry ; Anti-Inflammatory Agents/pharmacology ; Cornea ; Particle Size

المؤلفون: Beckman K; Comprehensive Eyecare of Central Ohio, Westerville, Ohio, USA.; Department of Ophthalmology, Ohio State University, Columbus, Ohio, USA., Katz J; The Midwest Center for Sight, Des Plaines, Illinois, USA., Majmudar P; Chicago Cornea Consultants, Hoffman Estates, Illinois, USA., Rostov A; Northwest Eye Surgeons, Seattle, Washington, USA.

المصدر: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics [J Ocul Pharmacol Ther] 2020 Sep; Vol. 36 (7), pp. 497-511. Date of Electronic Publication: 2020 May 08.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: Association For Ocular Pharmacology And Therapeutics Country of Publication: United States NLM ID: 9511091 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-7732 (Electronic) Linking ISSN: 10807683 NLM ISO Abbreviation: J Ocul Pharmacol Ther Subsets: MEDLINE

مواضيع طبية MeSH: Anti-Allergic Agents/*administration & dosage , Dry Eye Syndromes/*drug therapy , Loteprednol Etabonate/*administration & dosage, Animals ; Anti-Allergic Agents/adverse effects ; Cyclosporine/administration & dosage ; Cyclosporine/adverse effects ; Dry Eye Syndromes/pathology ; Humans ; Inflammation/drug therapy ; Inflammation/pathology ; Loteprednol Etabonate/adverse effects ; Lubricant Eye Drops/administration & dosage ; Quality of Life